Mortality and economic costs from regular cigar use in the United States, 2010

American Journal of Public Health

Volumn 104, Issue 9, 2014, Pages

  Nonnemaker, James ^a   Rostron, Brian ^b   Hall, Patricia ^b   MacMonegle, Anna ^a   Apelberg, Benjamin ^b  

^a RTI INTERNATIONAL   (United States)

^b CENTER FOR TOBACCO PRODUCTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COST OF ILLNESS; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; PREVALENCE; RESPIRATORY TRACT DISEASE; SMOKING; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; COST OF ILLNESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, ECONOMIC; NEOPLASMS; PREVALENCE; RESPIRATORY TRACT DISEASES; SMOKING; UNITED STATES;

EID: 84904874575     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2014.301991     Document Type: Article

References (28)

1. Centers for Disease Control and Prevention. Consumption of cigarettes and combustible tobacco-United States, 2000-2011. MMWR Morb Mortal Wkly Rep. 2012;61(30):565-569.
2. Cullen J, Mowery P, Delnevo C, et al. Seven-year patterns in US cigar use epidemiology among young adults aged 18-25 years: a focus on race/ethnicity and brand. Am J Public Health. 2011;101(10):1955-1962.
3. King BA, Tynan MA, Dube SR, Arrazola R. Flavored-little-cigar and flavored-cigarette use among U.S. middle and high school students. J Adolesc Health. 2014;54(1):40-46.
4. Centers for Disease Control and Prevention. Tobacco product use among middle and high school students-United States, 2011 and 2012. MMWR Morb Mortal Wkly Rep. 2013;62(45):893-897.
5. King BA, Dube SR, Tynan MA. Current tobacco use among adults in the United States: findings from the National Adult Tobacco Survey. Am J Public Health. 2012;102(11):e93-e100.
6. Hoffmann D, Hoffmann I. Chemistry and toxicology. In: Burns D, Cummings KM, Hoffman D, eds. Cigars: Health Effects and Trends. Bethesda, MD: US Department of Health and Human Services; 1998.
7. Shanks TG, Burns DM. Disease consequences of cigar smoking. In: Burns D, Cummings KM, Hoffman D, eds. Cigars: Health Effects and Trends. Bethesda, MD: US Department of Health and Human Services; 1998.
8. International Agency for Research on Cancer. Tobacco Smoke and Involuntary Smoke. Lyon, France: World Health Organization; 2004.
9. Centers for Disease Control and Prevention. Smoking-Attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57(45): 1226-1228.
10. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General, 2014. Rockville, MD; 2014.
11. Levin ML. The occurrence of lung cancer in man. Acta Unio Int Contra Cancrum. 1953;9(3):531-541.
12. Shapiro JA, Jacobs EJ, Thun MJ. Cigar smoking in men and risk of death from tobacco-related cancers. J Natl Cancer Inst. 2000;92(4):333-337.
13. Jacobs EJ, Thun MJ, Apicella LF. Cigar smoking and death from coronary heart disease in a prospective study of US men. Arch Intern Med. 1999;159(20):2413-2418.
14. Iribarren C, Tekawa IS, Sidney S, Friedman GD. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl JMed. 1999;340(23):1773-1780.
15. Rodriguez J, Jiang R, Johnson WC, MacKenzie BA, Smith LJ, Barr RG. The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study. Ann Intern Med. 2010; 152(4):201-210.
16. Fabian LA, Canlas LL, Potts J, Pickworth WB. Ad lib smoking of Black &Mild cigarillos and cigarettes. Nicotine Tob Res. 2012;14(3):368-371.
17. Murphy SL, Xu JQ, Kochanek KD. Deaths: final data for 2010. Natl Vital Stat Rep. 2013;61(4):1-167.
18. Arias E. United States life tables, 2008. Natl Vital Stat Rep. 2012;61(3):10-15.
19. Hammitt JK. Valuing changes in mortality risk: lives saved versus life years saved. Rev Environ Econ Policy. 2002;1(2):228-240.
20. Viscusi WK, Hersch J. The mortality cost to smokers. J Health Econ. 2008;27(4):943-958.
21. Cutler DM. Are we finally winning the war on cancer? J Econ Perspect. 2008;22(4):3-26.
22. Food and Drug Administration. Required warnings for cigarette packages and advertisements. Fed Regist. 2011;76(120):36709.
23. Murphy KM, Topel RH. The value of health and longevity. J Polit Econ. 2006;114(5):871-904.
24. Viscusi WK, Aldy JE. The value of a statistical life: a critical review of market estimates throughout the world. J Risk Uncertainty. 2003;27(1):5-76.
25. Food and Drug Administration. Prevention of Salmonella Enteritidis in shell eggs during production, storage, and transportation. Fed Regist. 2009;74(130):33056.
26. Fant RV, Henningfield JE. Pharmacology and abuse potential of cigars. In: Burns DM, Cummings KM, Hoffman D, eds. Cigars: Health Effects and Trends. Bethesda, MD: US Department of Health and Human Services; 1998:181-193.
27. Delnevo CD, Hrywna M. "A whole 'nother smoke" or a cigarette in disguise: how RJ Reynolds reframed the image of little cigars. Am J Public Health. 2007;97(8): 1368-1375.
28. Henningfield JE, Fant RV, Radzius A, Frost S. Nicotine concentration, smoke pH and whole tobacco aqueous pH of some cigar brands and types popular in the United States. Nicotine Tob Res. 1999;1(2):163-168.